Oscar Health Reports Q1 Revenue Surge to $3.05 Billion

Oscar Health reported robust financial results for the first quarter of 2025, with earnings per share of $0.92 and revenue reaching $3.05 billion—both figures exceeding analyst expectations and representing a 42% year-over-year revenue increase. The company saw its total membership rise to over 2 million, up significantly from the previous year, contributing to improved operational performance and higher net income. Although the medical loss ratio increased slightly to 75.4%, Oscar Health managed to reduce its SG&A expense ratio and achieved a notable rise in adjusted EBITDA. The leadership reaffirmed confidence in the company's full-year 2025 outlook, emphasizing continued margin expansion and value for members. Analysts project a potential upside for the stock, with one-year price targets averaging $18.28, reflecting nearly 40% growth from the current price, and maintain a consensus 'Hold' recommendation. Oscar Health's strong quarter was further recognized by a 16% surge in its stock price following the earnings announcement.